European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

Rentschler Biopharma SE, Laupheim, Germany

Watch
Rentschler Biopharma SE

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Premium Service
Unlock Dossier
What is a Dossier?
A dossier is a comprehensive company details as a PDF and publications in one place.
The download feature is exclusively available for our paid plan. Upgrade your account to access:
Quick Dossier
Entire company details as a PDF
Complete Dossier
Entire company details along with publications bundled in a ZIP file
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more
Learn more
View plans
Risk report
Rentschler Biopharma SE
Risk Level Evaluation Source
Sanctioned (?)

Name

Rentschler Biopharma SE
Rentschler SE
Atrium 68. Europäische VV SE

Identification

Ut
District Court of Ulm HRB 731612
Ut
District Court of Frankfurt HRB 99696
Lei
52990049AP5D6OOSFX02
EUID
DEB8537.HRB731612

Address

Erwin-Rentschler-Str. 21, 88471 Laupheim, Germany
Bonn, Germany

Corporate purpose

The research, development, manufacture and/or distribution of processes, substances and products in the field of biotechnology.

Financial performance

Employees

For this company, Employees numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

History

Persons

Marketing & Tech

Network

Loading network

Legal Structure

Current legal representatives Legal form information · Proxy policies Premium
Premium
3Member of the Executive Board
4Authorized signatory (ppa)
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans
Ownership relations Premium + Ownership & Flags add-on
Premium + Ownership & Flags add-on
Shareholders and Investors
2 known active shareholders
Portfolio and Investments
One known active shareholding
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans

Financials

Key Performance Indicators Financial · Mktg & Tech Premium
Premium
Base/share capital
Total assets
Earnings
Earnings CAGR
Revenue
Revenue CAGR
Return on sales
Equity
Equity ratio
Return on equity
Employee number
Revenue per employee
Taxes
Tax ratio
Cash on hand
Receivables
Liabilities
Cost of materials
Wages and salaries
Average salaries per employee
Pension provisions
Real estate
Total public funding
Number of public fundings
Trademarks
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans
Financial Statements Interactive sheets with CSV/Excel download Premium
Premium
Balance
from 2015 to 2025
Profit & Loss
from 2017 to 2025
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans

Publications

5 Aug 2026
Member of the Executive Board: Torsten Wöhr · No longer Member of the Executive Board: Uwe Bücheler
8 Apr 2026
Annual report for the year ending 31/03/2025 · Balance sheet for 31/03/2025 · Earnings statement for 31/03/2025 · SH: Rentschler Atmp Ltd., Rentschler Biopharma Inc., Rentschler Biotechnologie …
18 Mar 2026
Member of the Executive Board: Veit Bergendahl
13 Mar 2026 via Dr. Rentschler Holding GmbH & Co.KG also 02/07/2025, 06/03/2024, 02/05/2023, 09/05/2022, 09/04/2021, 07/04/2020, 03/04/2019, 09/04/2018, 28/04/2017, 06/06/2016
Shareholder: Dr. Rentschler Holding GmbH & Co.KG
3 Mar 2026
No longer Member of the Executive Board: Christiane Bardroff
25 Feb 2026
No longer Member of the Executive Board: B. von Braunmühl
24 Feb 2026
Member of the Executive Board: Uwe Bücheler
9 Feb 2026
List of board members
5 Feb 2026
Original document: “Liste der Aufsichtsratsmitglieder zum 05.02.2026“
13 Aug 2025
Annual report for the year ending 31/03/2022
13 Aug 2025
Annual report for the year ending 31/03/2023
3 Jun 2025
Annual report for the year ending 31/03/2024 · Balance sheet for 31/03/2024 · Earnings statement for 31/03/2024 · SH: Rentschler Atmp Ltd., Rentschler Biopharma Inc., Rentschler Biotechnologie …
22 May 2025
Authorized signatory (ppa): Patrick Meyer
31 Mar 2025
Authorized signatory (ppa): Thomas Froneck
12 Dec 2024
No longer Authorized signatory (ppa): Federico Pollano
5 Nov 2024
No longer Authorized signatory (ppa): Thomas Froneck
1 Sept 2024
Annual report for the year ending 31/03/2024
16 Jul 2024
Annual report for the year ending 31/03/2023 · Balance sheet for 31/03/2023 · Earnings statement for 31/03/2023 · SH: Rentschler Atmp Ltd., Rentschler Biopharma Inc., Rentschler Biotechnologie …
13 Mar 2024
No longer Member of the Executive Board: Christian Schetter
5 Feb 2024
Member of the Executive Board: G. Voss-von Dahlen
17 Oct 2023
No longer Member of the Executive Board: Alexander Dettmer
11 Oct 2023
Member of the Executive Board: B. von Braunmühl
1 Jun 2023
Annual report for the year ending 31/03/2022 · Balance sheet for 31/03/2022 · Earnings statement for 31/03/2022 · Shareholder (4 companies)
6 Apr 2023
Authorized signatory (ppa): Tobias Glück · No longer Member of the Executive Board: Frank Mathias
3 Jan 2023
No longer Authorized signatory (ppa) (1)
19 Dec 2022
Member of the Executive Board: Christiane Bardroff · Authorized signatory (ppa): Andreas Löwe
13 Jul 2022
No longer Authorized signatory (ppa) (1)
31 May 2022
Annual report for the year ending 31/03/2020
31 May 2022
Word figurative mark: “Xpert Alliance RENTSCHLER & VETTER SUBSTANCE PRODUCT PATIENT“
20 Apr 2022
Annual report for the year ending 31/03/2021 · Balance sheet for 31/03/2021 · Earnings statement for 31/03/2020 · Shareholdings: Rentschler ATMP Ltd., Rentschler Biopharma Inc
1 Mar 2022
No longer Authorized signatory (ppa) (1)
1 Jan 2022 in Fk
Public funding (€3,112.00): QSens: Quantum Sensors for Biomedical Diagnostics (QMED) - D
1 Oct 2021
Member of the Executive Board: Christian Schetter
31 May 2021
Authorized signatory (ppa) (1)
25 May 2021
List of board members
18 May 2021
Original document: “Liste der Aufsichtsratsmitglieder zum 18.05.2021“
4 May 2021
Annual report for the year ending 31/03/2020 · Balance sheet for 31/03/2020 · Earnings statement for 31/03/2020 · Shareholding: Rentschler Biopharma Inc
18 Mar 2021
Patent: Device and method for sealing syringe bodies
6 Jul 2020
Member of the Executive Board: Alexander Dettmer · No longer Member of the Executive Board: Stefan Georg Rampf
4 Jun 2020
No longer Member of the Executive Board: Ralf Otto
13 May 2020
Authorized signatory (ppa) (1)
1 Apr 2020
Annual report for the year ending 31/03/2019 · Balance sheet for 31/03/2019 · Earnings statement for 31/03/2018 · Shareholding: Rentschler Biopharma Inc
30 Jan 2020
Bekanntmachung nach § 20 Abs. 6 Aktiengesetz (AktG)
29 Nov 2019
No longer Authorized signatory (ppa) (2)
14 May 2019
Annual report for the year ending 31/03/2018 · Balance sheet for 31/03/2018 · Earnings statement for 31/03/2018
10 Apr 2019 via Rentschler Biotechnologie Beteiligungs GmbH
Shareholder: Rentschler Biotechnologie Beteiligungs GmbH
14 Dec 2018
Authorized signatory (ppa) (2)
15 Aug 2018
No longer Authorized signatory (ppa) (1)
9 May 2018
Annual report for the year ending 31/03/2017 · Balance sheet for 31/03/2017
1 May 2018 in Hor
EU funding: Integrated control and sensing platform for biopharmaceutical cultivation process high-throughput development and production
21 Mar 2018
No longer Authorized signatory (ppa) (2)
7 Feb 2018
Member of the Executive Board: Ralf Otto · No longer Member of the Executive Board: Thomas Siklosi
14 Dec 2017
No longer Authorized signatory (ppa) (1)
16 Oct 2017
Member of the Executive Board: Thomas Siklosi · Authorized signatory (ppa) (6) · Capital: €30M · Company statute
21 Sept 2017
Original document: “Gesellschaftsvertrag / Satzung / Statut“
4 Aug 2017
Name: Rentschler Biopharma SE · Company statute · Corporate Purpose
2 Aug 2017
Original document: “Gesellschaftsvertrag / Satzung / Statut“
2 May 2017 as Rentschler SE
Annual report for the year ending 31/03/2016 · Balance sheet for 31/03/2016
6 Jul 2016 as Rentschler SE
Authorized signatory (ppa) (1) · No longer Authorized signatory (ppa) (1)
4 May 2016 as Rentschler SE
Member of the Executive Board: Stefan Georg Rampf · No longer Member of the Executive Board (1)
4 May 2016 as Rentschler SE
List of board members
4 May 2016
Original document: “Liste der Aufsichtsratsmitglieder zum 04.05.2016“
13 Apr 2016 as Rentschler SE
Member of the Executive Board: Frank Mathias · List of board members
8 Apr 2016
Original document: “Liste der Aufsichtsratsmitglieder zum 08.04.2016“
14 Oct 2015
Authorized signatory (ppa) (1)
9 Oct 2015
Wordmark: “Passion for Performance“
1 Oct 2015 as Rentschler SE
Authorized signatory (ppa) (2) · Merger: Rentschler Service GmbH · Capital: €170,000 · Company statute · Corporate Purpose
15 Sept 2015 as Rentschler SE
Merger: Rentschler Service GmbH
15 Sept 2015
Original document: “Gesellschaftsvertrag / Satzung / Statut“
15 Sept 2015
Original document: “Unternehmensvertrag / Umwandlungsvertrag / sonstiger Vertrag“
1 Sept 2015
Original document: “Unternehmensvertrag / Umwandlungsvertrag / sonstiger Vertrag“
15 Jan 2015 as Atrium 68. Europäische VV SE
Change of headquarters: Rentschler SE · Address · Seat: Laupheim
13 Jan 2015 as Rentschler SE
Member of the Executive Board (1) · No longer CxO (1) · Change of headquarters: Atrium 68. Europäische VV SE · Capital: €120,000 · Proxy policy · Company statute · Corporate Purpose
18 Nov 2014
Original document: “Gesellschaftsvertrag / Satzung / Statut“
18 Nov 2014
Original document: “Liste der Aufsichtsratsmitglieder zum 18.11.2014“
8 Jul 2014 as Atrium 68. Europäische VV SE
Reg­is­tra­tion · Member of the Executive Board (1) · Address · Capital: €120,000 · Proxy policy · Corporate Purpose
23 Jun 2014
Original document: “Gesellschaftsvertrag / Satzung / Statut“
There are no publications matching your search.

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Printing is only available to North Data premium service subscribers.